The investigation aimed to elucidate the potential impact of CD47 interaction with TNFRSF9 within the tumor immune microenvironment (TIME) on CD8 + T cell functionality and its consequent effect on the prognosis of patients with malignant tumors. Here, TNFRSF9 is linked to cancer.